p53 can be cancer's friend, not foe

被引：0
|
作者：
机构：
来源：
Nature | 2012年 / 487卷 / 7407期
关键词：
D O I：
10.1038/487275e
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：275 / 275
相关论文
共 50 条
  • [21] Inflammation and cancer: friend or foe?
    Turizo-Smith, Andres David
    Cordoba-Hernandez, Samantha
    Mejia-Guarnizo, Lidy Vannessa
    Monroy-Camacho, Paula Stefany
    Rodriguez-Garcia, Josefa Antonia
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [22] Fibronectin in Cancer: Friend or Foe
    Lin, Tsung-Cheng
    Yang, Cheng-Han
    Cheng, Li-Hsin
    Chang, Wen-Tsan
    Lin, Yuh-Rong
    Cheng, Hung-Chi
    CELLS, 2020, 9 (01)
  • [23] ATR and cancer: friend or foe?
    Fernandez-Capetillo, Oscar
    CHROMOSOME RESEARCH, 2011, 19 : S15 - S15
  • [24] Opioids and cancer: friend or foe?
    Wigmore, Timothy
    Farquhar-Smith, Paul
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2016, 10 (02) : 109 - 118
  • [25] β-Galactosylceramidase in cancer: friend or foe?
    Presta, Marco
    TRENDS IN CANCER, 2021, 7 (11): : 974 - 977
  • [26] Cancer and necroptosis: friend or foe?
    Philipp, Stephan
    Sosna, Justyna
    Adam, Dieter
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2016, 73 (11-12) : 2183 - 2193
  • [27] Fibulins and cancer: friend or foe?
    Gallagher, WM
    Currid, CA
    Whelan, LC
    TRENDS IN MOLECULAR MEDICINE, 2005, 11 (07) : 336 - 340
  • [28] Can less be more for p53?
    Anton Berns
    Nature, 2006, 443 : 153 - 154
  • [29] Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ
    Solomon, H.
    Sharon, M.
    Rotter, V.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (09): : 1347 - 1349
  • [30] Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ
    H Solomon
    M Sharon
    V Rotter
    Cell Death & Differentiation, 2014, 21 : 1347 - 1349
12345